The Europe Syringe Infusion Pump Market was valued at USD 465.1 million in 2024, and is projected to reach USD 729.5 million by 2030, rising at a CAGR of 7.90%. The increasing incidence of preterm births, the rising prevalence of chronic diseases, and healthcare providers' focus on incorporating advanced technology-driven equipment are leading to growth in the adoption of syringe infusion pumps in Europe.
Growing new cases of cancer, a significant increase in patients diagnosed with diabetes, and continuous growth in patients admitted to intensive care units for treatments associated with complex health conditions are expected to generate growth for this market. The launch of innovation-based products with key features such as real-time monitoring and control devices is expected to drive growth and adoption across hospitals and healthcare facilities.
Significant advancements driven by innovation, research-based product developments, and stringent regulatory requirements regarding the safety and quality of medical devices and equipment are expected to influence this market positively. The rising adoption of controlled delivery of medications and precision dosing in critical care applications is anticipated to create lucrative growth opportunities over the forecast period.
This product will be delivered within 2 business days.
Growing new cases of cancer, a significant increase in patients diagnosed with diabetes, and continuous growth in patients admitted to intensive care units for treatments associated with complex health conditions are expected to generate growth for this market. The launch of innovation-based products with key features such as real-time monitoring and control devices is expected to drive growth and adoption across hospitals and healthcare facilities.
Significant advancements driven by innovation, research-based product developments, and stringent regulatory requirements regarding the safety and quality of medical devices and equipment are expected to influence this market positively. The rising adoption of controlled delivery of medications and precision dosing in critical care applications is anticipated to create lucrative growth opportunities over the forecast period.
Europe Syringe Infusion Pump Market Report Highlights
- Based on disease type, the pediatrics/neonatology segment led the market with the largest revenue share of 26.2% in 2024, owing to the significant assistance of syringe infusion pumps in controlled drug delivery while treating newborns and advanced technological capabilities.
- The chemotherapy segment is projected to experience at the fastest CAGR over the forecast period.
- The increasing incidence of chronic disease, primarily cancer, and the growing integration of palliative care with cancer treatments fuel the market growth.
- Based on end use, the hospitals segment accounted for the largest market revenue share in 2024, owing to their increasing application in multiple treatments that require precision dosing and controlled drug delivery.
- The home care segment is projected to grow at the fastest CAGR from 2025 to 2030
- Germany dominated the market with the largest revenue share in 2024, with multiple manufacturers and growing applications in intensive and critical care, chemotherapy, pain management, and other areas.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Europe Syringe Infusion Pumps Market Variables, Trends & Scope
Chapter 4. Europe Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis
Chapter 5. Europe Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis
Chapter 6. Europe Syringe Infusion Pumps Market: Country Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies featured in this Europe Syringe Infusion Pump market report include:- B. Braun SE
- Baxter
- BD
- Fresenius Kabi AG
- Micrel Medical Devices SA
- CODAN Companies
- Arcomed
- ICU Medical, Inc. (Smiths Medical)
- Terumo Corporation
- Moog Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | May 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 465.1 Million |
| Forecasted Market Value ( USD | $ 729.5 Million |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 11 |
